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The KCL036 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominantmutation affecting one allele of theHTT gene encoding huntingtin (38 trinucleotide repeats;
14 for the normal allele). The ICMwas isolated using laser microsurgery and plated on γ-irradiated human fore-
skinﬁbroblasts. Both the derivation and cell line propagationwere performed in an animal product-free environ-
ment. Pluripotent state and differentiation potential were conﬁrmed by in vitro and in vivo assays.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Resource table
Name of stem
cell line
KCL036
Institution King's College London, London UK
Derivation team
Neli Kadeva, Victoria Wood, Glenda Cornwell, Stefano
Codognotto, Emma Stephenson
Contact person
and email
Dusko Ilic, email: dusko.ilic@kcl.ac.uk
Date archived/
stock date
Nov 22, 2011
Type of resource Biological reagent: cell line
Sub-type Human pluripotent stem cell line
Origin Human embryo
Key marker
expression
Pluripotent stem cell markers: NANOG, OCT4, TRA-1-60,
TRA-1-81, alkaline phosphatase (AP) activity
Authentication Identity and purity of line conﬁrmed
Link to related
literature
(direct URL
links and full
references)
1) Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson, D.,
Petrova, A., Kadeva, N., Codognotto, S., Patel, H., Semple, M.,
Cornwell, G., Ogilvie, C., Braude, P., 2012. Derivation and
feeder-free propagation of human embryonic stem cells
under xeno-free conditions. Cytotherapy. 14 (1), 122–128.
doi: 10.3109/14,653,249.2011.623692
http://www.ncbi.nlm.nih.gov/pubmed/22029654
2) Stephenson, E., Jacquet, L., Miere, C., Wood, V., Kadeva, N.,
Cornwell, G., Codognotto, S., Dajani, Y., Braude, P., Ilic, D.,
2012. Derivation and propagation of human embryonic
stem cell lines from frozen embryos in an animal
product-free environment. Nat. Protoc. 7 (7), 1366–1381.
doi: 10.1038/nprot.2012.080
http://www.ncbi.nlm.nih.gov/pubmed/22722371
(continued)
Name of stem
cell line
KCL036
3) Jacquet, L., Neueder, A., Földes, G., Karagiannis, P., Hobbs, C.,
Jolinon, N., Mioulane, M., Sakai, T., Harding, S.E., Ilic, D., 2015.
Three Huntington's Disease Speciﬁc Mutation-Carrying
Human Embryonic Stem Cell Lines Have Stable Number of
CAG Repeats upon In Vitro Differentiation into
Cardiomyocytes. PLoS One. 10(5), e0126860.
http://www.ncbi.nlm.nih.gov/pubmed/25993131
Information in
public
databases
KCL036 is a National Institutes of Health (NIH) registered hESC
line
NIH Registration Number: 0241
NIH Approval Number: NIHhESC-13-0241
http://grants.nih.gov/stem_cells/registry/current.htm?id=668
Ethics
The hESC line KCL036 is derived under license from the UK
Human Fertilisation and Embryology Authority (research
license numbers: R0075 and R0133) and also has local ethical
approval (UK National Health Service Research Ethics
Committee Reference: 06/Q0702/90).
Informed consent was obtained from all subjects and the
experiments conformed to the principles set out in the WMA
Declaration of Helsinki and the NIH Belmont Report. No
ﬁnancial inducements are offered for donation.
Resource details
Consent signed Jul 21, 2011
Embryo thawed Oct 23, 2011
UK Stem Cell Bank
Deposit Approval
Sep 13, 2012
Reference: SCSC12-28
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Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scr
(continued)
Consent signed Jul 21, 2011
Sex Male 46, XY
Grade Research
Disease status
(Fig. 1)
Mutation affecting one allele of the HTT gene
encoding huntingtin (~38 CAG repeats; 14 for the
normal allele) associated with Huntington's
disease (Ilic et al., 2015)
Karyotype (aCGH)
Decreased copy number at 2q37.3
(242,930,599–242,948,040) and at 3q25.1
(151,368,847–151,542,568). The imbalances are
considered to be benign copy number variants. The
chromosome 3 imbalance was not called by
software.
DNA ﬁngerprint
Allele sizes (in bp) of 17 microsatellite markers
speciﬁc for chromosomes 13, 18 and 21 (Jacquet
et al., 2015)
Viability testing Pass
Pluripotent markers
(immunostaining)
(Fig. 2)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
(Jacquet et al., 2015)
Three germ layers
differentiation in vitro
(immunostaining)
(Fig. 3)
Endoderm: AFP (α-fetoprotein); Ectoderm: TUBB3
(tubulin, β3 class III); Mesoderm: ACTA2 (actin,
α2, smooth muscle) (Jacquet et al., 2015)
Three germ layer
differentiation in vivo
(teratomas)
(Fig. 4)
Endoderm: AFP, GATA4. Ectoderm: TUBB3, GFAP
(glial ﬁbrillary acidic protein). Mesoderm: DES
(desmin), Alcian Blue and periodic acid–Schiff
(PAS)-stained cartilage (Jacquet et al., 2015)
Targeted differentiation
(Fig. 5)
Cardiomyocytes: TNNT2 (cardiac troponin T)
immunostaining
Sibling lines available None
We generated KCL036 research grade hESC line following protocols
established previously (Ilic et al., 2012; Stephenson et al., 2012;
Jacquet et al., 2013). The expression of the pluripotency markers was
tested after freeze/thaw cycle (Fig. 2; Jacquet et al., 2015). Differentia-
tion potential into three germ layers was veriﬁed in vitro (Fig. 3 and
Fig. 5; Jacquet et al., 2015) and in vivo (Fig. 4; Jacquet et al., 2015).
Validation for sterility and speciﬁc and non-speciﬁc human
pathogens conﬁrmed that the cells in Master Bank were sterile,
mycoplasma-free, and negative for human immunodeﬁciency virus 1
(HIV-1), Human T-lymphotropic virus type 1 (HTLV-1), hepatitis B
and C (HBV and HCV), human herpes simplex virus HHV-4 (Epstein–
Barr virus, EBV), and human cytomegalovirus (hCMV).
We also generated research grade of KCL036 line that is adapted to
feeder-free conditions (Jacquet et al., 2015).
Materials and methods
Consenting process
We distribute patient information sheets (PIS) and consent forms to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in themeantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.9) were created on Feb. 09, 2011.
HFEA Code of Practice that was in effect at the time of document crea-
tion: Edition 8—R.2 (http://www.hfea.gov.uk/2999.html). The donor
couple signed the consent on Jul. 21, 2011. HFEA Code of Practice that
was in effect at the time of donor signature: Edition 8—R.3. HFEA Code
of Practice Edition 8—R.2 was in effect: Apr. 07, 2010–Apr. 06, 2011.
HFEA Code of Practice Edition 8—R.3 was in effect: Apr. 07, 2011–Oct.
01, 2011.
Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
Cell culture
ICM plated on mitotically inactivated HFF were cultured as de-
scribed (Ilic et al., 2012; Stephenson et al., 2012). TE cells were re-
moved mechanically from outgrowth (Ilic et al., 2007; Ilic et al.,
2010). hESC colonies were expanded and cryopreserved at the third
passage.
Viability test
Straws with the earliest frozen passage (p.2–3) are thawed and
new colonies are counted 3 days later. These colonies are then ex-
panded up to passage 8, at which point cells were part frozen and
part subjected to standard battery of tests (pluripotency markers,
in vitro and in vivo differentiation capability, genetics, sterility,
mycoplasma).
Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro and in vivo (Jacquet et al., 2015) as described (Ilic et al., 2012;
Stephenson et al., 2012; Petrova et al., 2014). Targeted differentiation
in cardiomyocytes followed the protocols described earlier (Jacquet
et al., 2015; Laﬂamme et al., 2007).
Genotyping
DNA was extracted from hESC cultures using a Chemagen DNA
extraction robot according to the manufacturer's instructions.
Fig. 1.Genetic pedigree tree. The couple undergoing IVF had 16 embryos in this particular
cycle. Three embryos were normal, whereas those that carried the mutation in HTTwere
donated for research. We derived hESC lines from two of them.
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Ampliﬁcation of polymorphic microsatellite markers was carried out as
described (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
Special pathology
The Doctors Laboratory London (UK) tested the line for HIV1, HepB,
HepC, CMV, and EBV by PCR.
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Fig. 3. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smooth muscle actin (ACTA2, red) for mesoderm, β-III tubulin (TUBB3, red) for ectoderm,
and α-fetoprotein (AFP, red) for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 25 μm.
Fig. 4. Differentiation of three germ layers in vivo. Teratomas were encapsulated and did not invade surrounding tissue. Sections are counterstained with hematoxylin and eosin and
speciﬁc stains are brown (immunohistochemistry). Germ layer marker: DES for mesoderm, TUBB3 for ectoderm, and AFP for endoderm. Scale bars are 100 μm.
Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Scale bar,
20 μm.
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